首页> 美国卫生研究院文献>Clinical Medicine Research >PS1-03: Expanding the Functional Scope of Institutional Review Board Review of Multi-Site Research in the HMO Research Network: from Data-Only Studies to Non-Clinical Interventions to Clinical Trials
【2h】

PS1-03: Expanding the Functional Scope of Institutional Review Board Review of Multi-Site Research in the HMO Research Network: from Data-Only Studies to Non-Clinical Interventions to Clinical Trials

机译:PS1-03:扩大机构审查委员会在HMO研究网络中进行多站点研究的职能范围:从仅数据研究非临床干预到临床试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background/AimsThe member institutions of the HMORN have long been concerned about their ability to conduct multi-site research in a timely and efficient manner. Frequently in the past, investigators in multi-site studies have felt constrained by the requirement of submitting proposed research to multiple IRBs. In June 2008, the HMORN Governing Board approved a Standard Operating Procedure (SOP) that streamlined this submission process for data-only studies (Version 1), and in September 2010, the SOP was revised (Version 2) to permit the inclusion of all HMORN multi-site research except clinical trials. IRB Administrators and Directors from around the HMORN met in December 2010 to discuss strategies for harmonizing clinical trials review as well as establishing a Network-wide IRB Authorization Agreement for the conduct of HMORN multi-site research.
机译:背景/目标长期以来,HMORN的成员机构一直担心其能否及时有效地开展多站点研究。过去,多站点研究的研究人员经常受到向多个IRB提交拟议研究的要求的限制。 2008年6月,HMORN理事会批准了标准操作程序(SOP),该程序简化了仅数据研究的提交流程(版本1),2010年9月,对SOP进行了修订(版本2),以允许将所有HMORN多站点研究(临床试验除外)。来自HMORN各地的IRB管理者和董事在2010年12月举行会议,讨论了统一临床试验审查的策略,并为开展HMORN多站点研究建立了网络范围的IRB授权协议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号